Cardiotoxicity

0
Pipeline Programs
2
Companies
1
Clinical Trials
0
Approved Products

Pipeline by Development Stage

Preclinical
Phase 1
Phase 1/2
Phase 2
Phase 2/3
Phase 3
On Market
0
0
0
0
0
0
0
Early DiscoveryClinical DevelopmentMarket

Competitive Landscape

1 companies ranked by most advanced pipeline stage

Lantheus Medical Imaging
1 program
Early Detection of Broken Hearts in Cancer PatientsN/A1 trial
Active Trials
NCT02086695CompletedEst. Sep 2015

Trial Timeline

Clinical trial activity over time

2021
2022
2023
2024
2025
2026
Lantheus Medical ImagingEarly Detection of Broken Hearts in Cancer Patients

Clinical Trials (1)

NCT02086695Lantheus Medical ImagingEarly Detection of Broken Hearts in Cancer Patients

Early Detection of Broken Hearts in Cancer Patients

Start: Jun 2013Est. completion: Sep 2015
N/ACompleted

Phase Legend

PreclinicalLab & animal studies
Phase 1Safety & dosing
Phase 2Efficacy testing
Phase 3Large-scale trials
On MarketApproved & available

Key Insights

2 companies competing in this space